Diazyme DZ-Lite iFlash Total beta-hCG Assay, Diazyme DZ-Lite iFlash 1800 Chemiluminescence Immunoassay Analyzer— 510(k) K212221

Substantially Equivalent

Diazyme Laboratories, Inc.

FDA 510(k) clearance K212221 for Diazyme DZ-Lite iFlash Total beta-hCG Assay, Diazyme DZ-Lite iFlash 1800 Chemiluminescence Immunoassay Analyzer, Substantially Equivalent on 2021-12-13. Applicant: Diazyme Laboratories, Inc..

Clearance details

Applicant
Diazyme Laboratories, Inc.
Product code
Code DHA
Advisory panel
Clinical Chemistry
Date received
Decision date
Decision
Substantially Equivalent
Clearance type
Traditional
Location
Poway, CA, US
Download summary PDFView on FDA.gov ↗

Adverse events under product code DHA

product code DHA
Malfunction
1,242
Total
1,242

Source: openFDA MAUDE database, through . Counts aggregate all devices under this product code, not just this specific clearance. Reports are submissions to FDA, not validated events. Search MAUDE directly →

Data sourced from openFDA. This site is unofficial and independent of the FDA.